Page last updated: 2024-10-30

leflunomide and AIDS-Related Opportunistic Infections

leflunomide has been researched along with AIDS-Related Opportunistic Infections in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alfano, G1
Fontana, F1
Guaraldi, G1
Cappelli, G1
Mussini, C1

Other Studies

1 other study available for leflunomide and AIDS-Related Opportunistic Infections

ArticleYear
Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.
    International journal of STD & AIDS, 2020, Volume: 31, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; BK Virus; CD4 Lymphocy

2020